AT&T (T) Stock Slides as Market Rises: Facts to Know Before You Trade

AT&T (T) recently closed down 2.48%, underperforming major indices, though its 5.38% monthly gain has outpaced the broader market and its sector. Ahead of its October 22, 2025 earnings, consensus estimates project a 10% year-over-year EPS decline to $0.54, despite a 2.45% revenue increase to $30.95 billion for the quarter, with similar trends for full-year forecasts. The stock currently holds a Zacks Rank #3 (Hold) and trades at a Forward P/E of 14.45, a notable discount to its industry average of 20.28, suggesting a potentially undervalued position despite anticipated earnings contraction.

Analysis

AT&T's stock exhibited recent weakness, closing down 2.48% against a rising market, yet this follows a period of strength where its 5.38% one-month gain outpaced both the S&P 500 and its sector. The forward-looking view presents a significant challenge of margin compression, as consensus estimates for the upcoming quarter project a 2.45% year-over-year revenue increase to $30.95 billion but a contrasting 10% decline in EPS to $0.54. This trend is expected to hold for the full year, with revenue projected to rise 2.16% while EPS falls 9.29%. Despite this negative earnings outlook, the stock's valuation appears discounted, with a Forward P/E ratio of 14.45 standing significantly below the industry average of 20.28. However, a PEG ratio of 3.66, slightly above the industry's 3.42, highlights concerns about its price relative to its weak growth forecast. The neutral sentiment is encapsulated by a Zacks Rank of #3 (Hold), supported by a marginal 0.06% upward revision in the consensus EPS estimate over the past 30 days, indicating stability but no strong conviction from analysts.

Key Decisions for Investors

• Investors should weigh the stock's discounted valuation, evidenced by a Forward P/E of 14.45, against the significant headwind of a projected 9.29% decline in full-year earnings.
• Monitor the upcoming earnings report on October 22, 2025, for any signs of margin stabilization, as the key risk highlighted by forecasts is shrinking profitability despite modest revenue growth.
• Given the neutral Zacks #3 (Hold) rating and conflicting signals, a patient approach may be warranted, as the stock's recent monthly outperformance could be challenged by the fundamental outlook unless the company demonstrates a path to reversing its earnings decline.